GO:0050163 oxaloacetate tautomerase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050163 (oxaloacetate tautomerase activity) catalyzes the reversible keto-enol isomerization of oxaloacetate to its enol form, a reaction that controls the availability of the enol tautomer for downstream metabolism.
• The enzyme was first purified from bovine heart mitochondria and later identified as inactive aconitase, linking tautomerase activity to a moonlighting function of an iron-sulfur cluster protein.
• Oxaloacetate tautomerase activity is distinct from the canonical TCA cycle enzyme activities and is thought to protect against metabolite damage and to regulate succinate dehydrogenase.
• FAHD1 (fumarylacetoacetate hydrolase domain-containing protein 1) has emerged as a mitochondrial oxaloacetate tautomerase in eukaryotes, with roles in metabolism and aging.
• Dysregulation of oxaloacetate tautomerase activity has been implicated in metabolic disorders, cancer, and neurodegeneration through its effects on mitochondrial function and redox balance.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the physiological roles of oxaloacetate tautomerase activity and its associated genes.
Description
Oxaloacetate tautomerase activity (GO:0050163) is a molecular function that catalyzes the interconversion of oxaloacetate and its enol tautomer, a reaction critical for maintaining metabolic flux through the tricarboxylic acid (TCA) cycle and related pathways. The enzyme was initially described in bovine heart mitochondria, where it was found to be a high-molecular-mass protein distinct from other TCA cycle enzymes. Subsequent studies identified this activity as an inactive form of aconitase, revealing a moonlighting role for an iron-sulfur cluster protein. The tautomerization of oxaloacetate is not merely a chemical curiosity; it influences the availability of oxaloacetate for condensation with acetyl-CoA and modulates the activity of succinate dehydrogenase, thereby impacting cellular respiration. In recent years, FAHD1 has been characterized as a mitochondrial oxaloacetate tautomerase in mammals, providing a molecular handle to study this activity in health and disease. Understanding GO:0050163 is therefore essential for researchers investigating mitochondrial metabolism, metabolite damage control, and the broader implications of TCA cycle dysfunction in human pathologies.
oxaloacetate tautomerase activity At A Glance
| GO ID | GO:0050163 |
|---|---|
| GO term | oxaloacetate tautomerase activity |
| Ontology | molecular_function |
| Synonym | oxalacetic keto-enol isomerase activity; oxaloacetate keto-enol-isomerase activity; oxaloacetate keto-enol tautomerase activity |
| Major function | Catalysis of the reversible keto-enol isomerization of oxaloacetate to enol-oxaloacetate |
| Reaction | oxaloacetate = enol-oxaloacetate |
| Cellular location | Mitochondrial matrix (in eukaryotes) |
| Associated proteins | FAHD1, aconitase (inactive form) |
| Physiological role | Regulation of oxaloacetate levels, succinate dehydrogenase activity, and metabolite damage control |
What Is GO:0050163?
According to the Gene Ontology, oxaloacetate tautomerase activity (GO:0050163) is defined as the catalysis of the reaction: oxaloacetate = enol-oxaloacetate. This isomerization involves the reversible conversion of the keto form of oxaloacetate to its enol form, a process that can occur non-enzymatically but is accelerated by the enzyme. The activity is also known as oxalacetic keto-enol isomerase activity, oxaloacetate keto-enol-isomerase activity, and oxaloacetate keto-enol tautomerase activity. It is a molecular function that contributes to metabolic processes, particularly those involving oxaloacetate, such as the TCA cycle and gluconeogenesis.
Why Is oxaloacetate tautomerase activity Important in Cell Biology?
Oxaloacetate tautomerase activity is important because it sits at the intersection of central carbon metabolism and mitochondrial signaling. By controlling the keto-enol equilibrium of oxaloacetate, this activity influences the concentration of a key TCA cycle intermediate that is also a precursor for gluconeogenesis and amino acid biosynthesis. The enzyme's ability to regulate succinate dehydrogenase, a component of both the TCA cycle and the electron transport chain, underscores its role in cellular respiration and energy production. Moreover, the identification of FAHD1 as a mammalian oxaloacetate tautomerase has linked this activity to aging, metabolic reprogramming, and disease states such as cancer and neurodegeneration. Understanding GO:0050163 is therefore crucial for researchers studying mitochondrial dysfunction, metabolic disorders, and the emerging field of metabolite damage control.
• Regulates TCA cycle flux by controlling oxaloacetate availability for citrate synthesis.
• Modulates succinate dehydrogenase activity, impacting both respiration and ROS production.
• Protects against metabolite damage by removing potentially toxic enol species.
• Involved in mitochondrial metabolism and has been linked to aging and longevity.
• Dysregulation is associated with cancer cell metabolic reprogramming.
• May contribute to neurodegeneration through mitochondrial dysfunction.
• Provides a target for metabolic engineering and drug discovery.
• Serves as a model for enzyme promiscuity and moonlighting functions.
• Essential for understanding iron-sulfur cluster protein biology.
• Facilitates cross-talk between TCA cycle and other metabolic pathways.
Molecular Mechanism of oxaloacetate tautomerase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs oxaloacetate and flips it into its enol form.
Oxaloacetate tautomerase binds the keto form of oxaloacetate and catalyzes its conversion to the enol tautomer through a general acid-base mechanism. The reaction is reversible, with the equilibrium favoring the keto form under physiological conditions. The enzyme was first purified from bovine heart mitochondria, where it was shown to be a high-molecular-mass protein. Later studies identified this activity as an inactive form of aconitase, suggesting that the tautomerase function may be a moonlighting activity of the iron-sulfur cluster protein.
Role of Metal Cofactors
In simple terms: Metal ions in the enzyme help stabilize the reaction.
The mitochondrial oxaloacetate tautomerase was found to be a high-molecular-mass protein that could be identified as inactive aconitase, an iron-sulfur cluster enzyme. The iron-sulfur cluster is essential for the structural integrity of aconitase, and its loss leads to the tautomerase activity. This suggests that the catalytic mechanism may involve metal coordination, although the exact role of the cluster in tautomerization remains to be fully elucidated.
Regulation by Metabolic Intermediates
In simple terms: Other molecules in the cell can turn the enzyme on or off.
Oxaloacetate tautomerase activity is regulated by the availability of its substrate and by interactions with other metabolic intermediates. For example, succinate dehydrogenase activity is modulated by the tautomerization of oxaloacetate, indicating a feedback loop between the enzyme and the respiratory chain. Additionally, the enzyme may be subject to redox regulation due to its iron-sulfur cluster, which is sensitive to oxidative stress.
FAHD1 as a Mammalian Oxaloacetate Tautomerase
In simple terms: A protein called FAHD1 does this job in human cells.
FAHD1 (fumarylacetoacetate hydrolase domain-containing protein 1) has been identified as a mitochondrial oxaloacetate tautomerase in mammals. A decade of research has revealed its role in mitochondrial metabolism, including the regulation of oxaloacetate levels and its impact on aging and disease. FAHD1 is a member of the FAH superfamily and utilizes a catalytic mechanism that may involve a divalent metal ion, although its exact catalytic residues are still under investigation.
Metabolite Damage Control
In simple terms: The enzyme cleans up potentially harmful molecules.
Oxaloacetate tautomerase activity is part of a broader metabolite damage control system that removes or repairs damaged metabolites. The enol form of oxaloacetate can be reactive and potentially toxic, and its conversion to the keto form by the tautomerase helps maintain metabolic homeostasis. This function is particularly important in the TCA cycle, where oxaloacetate is a central intermediate and its enolization could lead to side reactions.
Key Genes Involved in GO:0050163 oxaloacetate tautomerase activity
The following genes and proteins are directly or indirectly associated with oxaloacetate tautomerase activity (GO:0050163), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FAHD1 | Mitochondrial oxaloacetate tautomerase; regulates oxaloacetate levels | Linked to aging, cancer metabolism, and mitochondrial function |
| ACO2 | Aconitase; inactive form exhibits oxaloacetate tautomerase activity | Moonlighting function; iron-sulfur cluster biology |
| SDHA | Succinate dehydrogenase subunit A; activity regulated by oxaloacetate tautomerization | TCA cycle and respiratory chain regulation |
| SDHB | Succinate dehydrogenase subunit B; affected by oxaloacetate levels | TCA cycle and respiratory chain regulation |
| MDH2 | Malate dehydrogenase; interconverts malate and oxaloacetate | Provides substrate for tautomerase |
| PC | Pyruvate carboxylase; generates oxaloacetate | Gluconeogenesis and TCA cycle anaplerosis |
| CS | Citrate synthase; consumes oxaloacetate | TCA cycle flux |
| GOT2 | Aspartate aminotransferase; interconverts oxaloacetate and aspartate | Amino acid metabolism |
| FH | Fumarase; TCA cycle enzyme | Metabolite damage control |
| IDH3A | Isocitrate dehydrogenase; TCA cycle enzyme | Metabolic flux |
| OGDH | Oxoglutarate dehydrogenase; TCA cycle enzyme | Metabolic flux |
| SUCLA2 | Succinyl-CoA ligase; TCA cycle enzyme | Metabolic flux |
| SDHC | Succinate dehydrogenase subunit C | Respiratory chain |
| SDHD | Succinate dehydrogenase subunit D | Respiratory chain |
| DLD | Dihydrolipoamide dehydrogenase; links to TCA cycle | Redox regulation |
| MPC1 | Mitochondrial pyruvate carrier; supplies pyruvate for oxaloacetate synthesis | Metabolic integration |
| MPC2 | Mitochondrial pyruvate carrier; supplies pyruvate for oxaloacetate synthesis | Metabolic integration |
How Is oxaloacetate tautomerase activity Regulated?
Oxaloacetate tautomerase activity is regulated at multiple levels. The enzyme's substrate, oxaloacetate, is a central metabolite whose concentration fluctuates with nutritional and hormonal signals. For instance, succinate dehydrogenase activity is modulated by the tautomerization of oxaloacetate, creating a feedback loop that adjusts TCA cycle flux and respiratory chain activity. Additionally, the iron-sulfur cluster of aconitase, which can exhibit tautomerase activity when inactive, is sensitive to oxidative stress and tellurite-mediated damage, linking enzyme activity to cellular redox status. In mammals, FAHD1 expression may be regulated by metabolic transcription factors, although the precise mechanisms remain to be fully defined.
oxaloacetate tautomerase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FAHD1 | Cancer, aging, metabolic disorders | FAHD1 knockout and overexpression cell lines |
| ACO2 | Neurodegeneration, mitochondrial myopathy | ACO2 mutant knock-in models |
| SDHA | Paraganglioma, pheochromocytoma | SDHA knockout cell models |
| SDHB | Paraganglioma, pheochromocytoma | SDHB knockout cell models |
| MDH2 | Metabolic disorders, cancer | MDH2 point mutation knock-in |
Cancer Metabolism
Altered mitochondrial metabolism is a hallmark of cancer, and oxaloacetate tautomerase activity may contribute to metabolic reprogramming. FAHD1, a mammalian oxaloacetate tautomerase, has been implicated in cancer cell proliferation and survival, with its expression correlating with tumor progression in some studies. By regulating oxaloacetate levels, this activity can influence the TCA cycle and support the biosynthetic demands of cancer cells.
Neurodegeneration
Mitochondrial dysfunction is a common feature of neurodegenerative diseases. The iron-sulfur cluster enzyme aconitase, which can exhibit oxaloacetate tautomerase activity when inactive, is particularly vulnerable to oxidative damage in neurons. Disruption of oxaloacetate homeostasis may contribute to neuronal death through impaired energy production and increased oxidative stress.
Metabolic Disorders
Dysregulation of oxaloacetate tautomerase activity has been linked to metabolic disorders such as diabetes and obesity. The enzyme's role in regulating succinate dehydrogenase and TCA cycle flux suggests that its dysfunction could contribute to insulin resistance and altered glucose metabolism. Furthermore, FAHD1 has been associated with aging and metabolic decline, highlighting its potential as a therapeutic target.
From oxaloacetate tautomerase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FAHD1 affect oxaloacetate levels and TCA cycle flux? | FAHD1 knockout cell line (e.g., HEK293T) |
| Does a specific point mutation in FAHD1 abolish tautomerase activity? | FAHD1 point mutation knock-in via CRISPR |
| Can FAHD1 overexpression rescue metabolic defects? | FAHD1 overexpression cell model |
| How does oxaloacetate tautomerase activity affect succinate dehydrogenase? | SDHA/SDHB knockout or knockdown |
| What is the role of aconitase moonlighting in tautomerization? | ACO2 knockout or point mutation |
| Does oxidative stress modulate tautomerase activity? | Tellurite-treated E. coli or mammalian cells |
How to Study the oxaloacetate tautomerase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric tautomerase assay | Enzyme activity by monitoring enol-oxaloacetate decay | Purified enzyme or cell lysate |
| LC-MS metabolomics | Oxaloacetate and TCA cycle intermediate levels | Knockout vs wild-type cells |
| CRISPR knockout screening | Genes required for cell fitness upon tautomerase loss | Cancer cell lines |
| Western blot | Protein expression of FAHD1, aconitase, SDH | Validation of knockout/overexpression |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulatory complexes |
| Seahorse respirometry | Mitochondrial respiration | Functional impact of tautomerase manipulation |
| RNA-seq | Transcriptional changes | Pathway analysis upon gene editing |
| Proteomics | Global protein expression changes | Systems-level analysis |
Enzymatic Assays
Oxaloacetate tautomerase activity can be measured spectrophotometrically by monitoring the decrease in absorbance at 280 nm due to the conversion of the enol form to the keto form, or by using coupled assays with lactate dehydrogenase or malate dehydrogenase. These assays are essential for validating the activity of purified enzymes or cell lysates.
Metabolomics
Mass spectrometry-based metabolomics allows the quantification of oxaloacetate and its enol tautomer in biological samples. This approach can reveal changes in TCA cycle intermediates upon genetic manipulation of oxaloacetate tautomerase genes.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate oxaloacetate tautomerase activity or that are synthetically lethal with its loss. Such screens are powerful for uncovering metabolic vulnerabilities and pathways connected to GO:0050163.
Protein-Protein Interaction Studies
Co-immunoprecipitation and proximity labeling can identify interacting partners of FAHD1 or aconitase, shedding light on the regulatory networks surrounding oxaloacetate tautomerase activity.
How CRISPR Can Be Used to Study GO:0050163 oxaloacetate tautomerase activity
Knockout
CRISPR-Cas9 knockout of FAHD1 or ACO2 can abolish oxaloacetate tautomerase activity, allowing researchers to study its role in TCA cycle flux, metabolite damage, and disease models. Knockout cell lines are valuable for identifying compensatory pathways and for drug sensitivity screens.
Point Mutation
Introducing specific point mutations in FAHD1 or ACO2 via CRISPR base editing or homology-directed repair can dissect catalytic residues and separate tautomerase activity from other functions. For example, mutations in the iron-sulfur cluster of aconitase can distinguish its isomerase and tautomerase activities.
Knock-in
Knock-in of tagged FAHD1 (e.g., FLAG or GFP) enables localization, interaction, and activity studies in endogenous settings. This approach preserves native regulation and can reveal tissue-specific or context-dependent functions of oxaloacetate tautomerase activity.
Overexpression
Overexpression of FAHD1 or aconitase can increase oxaloacetate tautomerase activity, providing a gain-of-function model to study metabolic reprogramming, resistance to oxidative stress, and effects on cell proliferation. Overexpression models are also useful for testing inhibitors or activators.
How EDITGENE Supports oxaloacetate tautomerase activity Research
Researchers studying oxaloacetate tautomerase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional validation.
Contact EDITGENE today to design your custom CRISPR model for oxaloacetate tautomerase activity research.
Frequently Asked Questions About oxaloacetate tautomerase activity
What is oxaloacetate tautomerase activity?
Oxaloacetate tautomerase activity (GO:0050163) is a molecular function that catalyzes the reversible conversion of oxaloacetate to its enol form, known as enol-oxaloacetate.
What genes are involved in oxaloacetate tautomerase activity?
Key genes include FAHD1, which encodes a mitochondrial oxaloacetate tautomerase, and ACO2, whose inactive form exhibits tautomerase activity.
What is the role of FAHD1 in oxaloacetate tautomerase activity?
FAHD1 is a mammalian mitochondrial enzyme that catalyzes the tautomerization of oxaloacetate and has been linked to aging and metabolic regulation.
How is oxaloacetate tautomerase activity measured?
It is typically measured spectrophotometrically by monitoring the decrease in absorbance at 280 nm as enol-oxaloacetate converts to the keto form, or by coupled enzymatic assays.
What diseases are associated with oxaloacetate tautomerase activity?
Dysregulation has been implicated in cancer metabolism, neurodegeneration, and metabolic disorders such as diabetes.
Is oxaloacetate tautomerase activity the same as aconitase?
No, but inactive aconitase can exhibit oxaloacetate tautomerase activity, representing a moonlighting function of the iron-sulfur cluster protein.
What is the reaction catalyzed by oxaloacetate tautomerase?
The reaction is: oxaloacetate = enol-oxaloacetate, a reversible keto-enol isomerization.
Where is oxaloacetate tautomerase located in the cell?
In eukaryotes, it is primarily found in the mitochondrial matrix.
Can CRISPR be used to study oxaloacetate tautomerase activity?
Yes, CRISPR knockout, knock-in, and point mutation models of FAHD1 or ACO2 are powerful tools to dissect the function of this activity.
What are the synonyms for oxaloacetate tautomerase activity?
Synonyms include oxalacetic keto-enol isomerase activity, oxaloacetate keto-enol-isomerase activity, and oxaloacetate keto-enol tautomerase activity.
Conclusion
Oxaloacetate tautomerase activity (GO:0050163) is a critical molecular function that regulates oxaloacetate homeostasis and TCA cycle flux. Its identification as a moonlighting activity of aconitase and the characterization of FAHD1 as a mammalian tautomerase have opened new avenues for understanding mitochondrial metabolism in health and disease. Continued research using CRISPR-based models and advanced metabolomics will further elucidate its roles in cancer, neurodegeneration, and metabolic disorders, potentially leading to novel therapeutic strategies.
References
- 1. Johnson JD et al.. 1986. Stereochemistry and function of oxaloacetate keto-enol tautomerase.. J Biol Chem 261(10):4535-41 PMID: 3957907
- 2. Niehaus TD et al.. 2020. Enzyme promiscuity, metabolite damage, and metabolite damage control systems of the tricarboxylic acid cycle.. FEBS J 287(7):1343-1358 PMID: 32149453
- 3. Cappuccio E et al.. 2025. FAHD1 and mitochondrial metabolism: a decade of pioneering discoveries.. FEBS J 292(12):2973-2991 PMID: 39642098
- 4. Burov VI et al.. 1989. [Oxaloacetate keto-enol tautomerase from bovine heart mitochondrial matrix].. Biokhimiia 54(11):1763-71 PMID: 2627549
- 5. Belikova YuO et al.. 1989. Identification of the high-molecular-mass mitochondrial oxaloacetate keto-enol tautomerase as inactive aconitase.. FEBS Lett 246(1-2):17-20 PMID: 2707435
- 6. Vinogradov AD et al.. 1989. Regulation of succinate dehydrogenase and tautomerization of oxaloacetate.. Adv Enzyme Regul 28:271-80 PMID: 2624174
- 7. Belikova YO et al.. 1988. Isolation and properties of oxaloacetate keto-enol-tautomerases from bovine heart mitochondria.. Biochim Biophys Acta 936(1):10-9 PMID: 3179281
- 8. Calderón IL et al.. 2009. Tellurite-mediated disabling of [4Fe-4S] clusters of Escherichia coli dehydratases.. Microbiology (Reading) 155(Pt 6):1840-1846 PMID: 19383690
